As the potential effector molecules involved in insulin resistance, the levels of mTOR, phosphorylated mTOR and downstream phosphorylated S6K were increased in the TNF-α and IL-6-treated groups (Fig. 2a), suggesting that the mTOR/S6K pathway may be involved in insulin resistance under inflammatory stress. This evidence concerns the gene RPS6KB1 and Insulin resistance.